A large multi-center orthopaedic clinical trial that Nebraska Medicine researchers are a part of seeks to reduce the risk of blood clots and/or bleeding after hip or knee replacement surgery.
Sept. 29, 2017, was the 19-year anniversary of Scott's diagnosis of non-Hodgkin's lymphoma and also marked the day that I was receiving my first chemotherapy treatment for my triple-negative breast cancer diagnosis.
You’re about to leave the Nebraska Medicine website. The other site may collect information about your visit, including your IP address. Do you want to continue?